{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:38:31Z","timestamp":1791257911256,"version":"4.1.0"},"reference-count":60,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Cerebral vasospasm and the resulting infarction remain the most devastating complications of aneurysmal subarachnoid hemorrhage (aSAH). Limited treatment options are available, with nimodipine as the only approved prophylactic medication. In addition to its anticoagulant properties, heparin also has a pleiotropic and anti-inflammatory effect that could be beneficial in vasospasm. In this study, the authors sought to evaluate the efficacy and safety of heparin in the treatment of aSAH.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n The PubMed, EBSCOhost, Europe PMC, and Cochrane Central databases were searched to find studies including patients with aSAH who were treated with intravenous unfractionated heparin (UFH) after an aneurysm-securing procedure. Studies that did not include a comparison with UFH or low-molecular-weight heparin in deep vein thrombosis prophylactic doses were excluded. The primary outcome was cerebral vasospasm, and the secondary outcomes were cerebral infarction, clinical deterioration caused by delayed cerebral ischemia, bleeding complications, and thromboembolism complications.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Overall, 5 nonrandomized studies were included; 4 studies evaluated the safety and 3 studies evaluated the efficacy of intravenous heparin. From the analysis of 3 studies with a total of 895 patients, administration of intravenous UFH for > 48 hours was related to a significantly lower rate of cerebral infarction (OR 0.44, 95% CI 0.25\u20130.79). No significant association was found with other efficacy outcomes. Regarding cognitive outcome, one study found a significant improvement in Montreal Cognitive Assessment scores; however, the functional outcome as indicated by the modified Rankin Scale score was not improved by heparin administration. From the analysis of 4 studies with 1099 patients, no significant increases in bleeding and other complications were found.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Administration of intravenous UFH for more than 48 hours reduced the rate of cerebral infarction with a good safety profile. This result supports the ongoing clinical trial.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2021.12.focus21419","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T07:20:16Z","timestamp":1646119216000},"page":"E9","source":"Crossref","is-referenced-by-count":17,"title":["Heparin in the treatment of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis"],"prefix":"10.3171","volume":"52","author":[{"given":"Patrick P.","family":"Lukito","sequence":"first","affiliation":[{"name":"Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendry","family":"Lie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Helsa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"July","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neuroscience Centre Siloam Hospital, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Banten, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"8","key":"b1","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1161\/STROKEAHA.110.581975","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi T","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519\u2013e536.10.1161\/STROKEAHA.110.58197520595669"},{"issue":"10069","key":"b2","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"Macdonald RL","year":"2017","unstructured":"Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655\u2013666.10.1016\/S0140-6736(16)30668-727637674"},{"issue":"12","key":"b3","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","article-title":"The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage","volume":"85","author":"Budohoski KP","year":"2014","unstructured":"Budohoski KP, Guilfoyle M, Helmy A, The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014;85(12):1343\u20131353.10.1136\/jnnp-2014-30771124847164"},{"issue":"12","key":"b4","series-title":"Curr Atheroscler Rep","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology","volume":"19","author":"Geraghty JR","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50.2906330010.1007\/s11883-017-0690-x"},{"key":"b5","series-title":"Biomed Res Int","doi-asserted-by":"publisher","first-page":"384342","DOI":"10.1155\/2014\/384342","article-title":"Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage","volume":"2014","author":"Miller BA","year":"2014","unstructured":"Miller BA, Turan N, Chau M, Pradilla G. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int. 2014;2014:384342.2510512310.1155\/2014\/384342"},{"issue":"3","key":"b6","series-title":"Cochrane Database Syst Rev","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJE, Feigin VL, Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277.17636626"},{"issue":"7","key":"b7","series-title":"CNS Neurol Disord Drug Targets","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/187152711798072383","article-title":"Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage","volume":"10","author":"Liu GJ","year":"2011","unstructured":"Liu GJ, Luo J, Zhang LP, Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets. 2011;10(7):834\u2013844.10.2174\/18715271179807238321999736"},{"issue":"7","key":"b8","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald RL","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u2013625.2164065110.1016\/S1474-4422(11)70108-9"},{"key":"b9","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fneur.2018.00292","article-title":"Neuroinflammation as a target for intervention in subarachnoid hemorrhage","volume":"9","author":"De Oliveria Manoel AL","year":"2018","unstructured":"De Oliveria Manoel AL, Loch Macdonald R. Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol. 2018;9:292.10.3389\/fneur.2018.00292"},{"issue":"8","key":"b10","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/jcbfm.2009.59","article-title":"Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial","volume":"29","author":"Vergouwen MDI","year":"2009","unstructured":"Vergouwen MDI, Meijers JC, Geskus RB, Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab. 2009;29(8):1444\u20131453.1945860510.1038\/jcbfm.2009.59"},{"issue":"5","key":"b11","series-title":"Molecules","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/molecules22050724","article-title":"Heparin and heparin-derivatives in post-subarachnoid hemorrhage brain injury: a multimodal therapy for a multimodal disease","volume":"22","author":"Hayman EG","year":"2017","unstructured":"Hayman EG, Patel AP, James RF, Simard JM. Heparin and heparin-derivatives in post-subarachnoid hemorrhage brain injury: a multimodal therapy for a multimodal disease. Molecules. 2017;22(5):724.10.3390\/molecules22050724"},{"key":"b12","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fneur.2018.00097","article-title":"Heparin: the silver bullet of aneurysmal subarachnoid hemorrhage?","volume":"9","author":"Khattar NK","year":"2018","unstructured":"Khattar NK, James RF. Heparin: the silver bullet of aneurysmal subarachnoid hemorrhage?. Front Neurol. 2018;9:97.10.3389\/fneur.2018.0009729636721"},{"issue":"1","key":"b13","series-title":"CNS Drug Rev","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-3458.2002.tb00213.x","article-title":"Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review","volume":"8","author":"Stutzmann JM","year":"2002","unstructured":"Stutzmann JM, Mary V, Wahl F, Grosjean-Piot O, Uzan A, Pratt J. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review. CNS Drug Rev. 2002;8(1):1\u201330.10.1111\/j.1527-3458.2002.tb00213.x"},{"issue":"10","key":"b14","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen MDI","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20132395.2079837010.1161\/STROKEAHA.110.589275"},{"issue":"6","key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3171\/2013.8.JNS1337","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment","volume":"119","author":"Simard JM","year":"2013","unstructured":"Simard JM, Aldrich EF, Schreibman D, James RF, Polifka A, Beaty N. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment. J Neurosurg. 2013;119(6):1611\u20131619.2403270610.3171\/2013.8.JNS1337"},{"issue":"7","key":"b16","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/neurintsurg-2016-012925","article-title":"Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional \u2018H\u2019 therapy in vasospasm treatment","volume":"9","author":"Bruder M","year":"2017","unstructured":"Bruder M, Won SY, Kashefiolasl S, Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional \u2018H\u2019 therapy in vasospasm treatment. J Neurointerv Surg. 2017;9(7):659\u2013663.10.1136\/neurintsurg-2016-01292528153852"},{"key":"b17","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1016\/j.wneu.2018.06.118","article-title":"Low-dose versus therapeutic range intravenous unfractionated heparin prophylaxis in the treatment of patients with severe aneurysmal subarachnoid hemorrhage after aneurysm occlusion","volume":"117","author":"Kunz M","year":"2018","unstructured":"Kunz M, Siller S, Nell C, Low-dose versus therapeutic range intravenous unfractionated heparin prophylaxis in the treatment of patients with severe aneurysmal subarachnoid hemorrhage after aneurysm occlusion. World Neurosurg. 2018;117:e705\u2013e711.2995906610.1016\/j.wneu.2018.06.118"},{"issue":"5","key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3171\/2017.11.JNS17894","article-title":"Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes","volume":"130","author":"James RF","year":"2019","unstructured":"James RF, Khattar NK, Aljuboori ZS, Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes. J Neurosurg. 2019;130(5):1460\u20131467.10.3171\/2017.11.JNS17894"},{"issue":"3","key":"b19","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/neuros\/nyaa473","article-title":"Low-dose intravenous heparin infusion after aneurysmal subarachnoid hemorrhage is associated with decreased risk of delayed neurological deficit and cerebral infarction","volume":"88","author":"Kole MJ","year":"2021","unstructured":"Kole MJ, Wessell AP, Ugiliweneza B, Low-dose intravenous heparin infusion after aneurysmal subarachnoid hemorrhage is associated with decreased risk of delayed neurological deficit and cerebral infarction. Neurosurgery. 2021;88(3):523\u2013530.10.1093\/neuros\/nyaa47333269390"},{"issue":"6","key":"b20","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3171\/jns.2003.99.6.0953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"Siironen J","year":"2003","unstructured":"Siironen J, Juvela S, Varis J, No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg. 2003;99(6):953\u2013959.10.3171\/jns.2003.99.6.095314705720"},{"issue":"2","key":"b21","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clineuro.2004.01.006","article-title":"Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo","volume":"106","author":"Wurm G","year":"2004","unstructured":"Wurm G, Tomancok B, Nussbaumer K, Adelw\u00f6hrer C, Holl K. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg. 2004;106(2):97\u2013103.1500329810.1016\/j.clineuro.2004.01.006"},{"issue":"5","key":"b22","series-title":"Thromb Res","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0049-3848(99)00125-5","article-title":"The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells","volume":"96","author":"Young E","year":"1999","unstructured":"Young E, Venner T, Ribau J, Shaughnessy S, Hirsh J, Podor TJ. The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells. Thromb Res. 1999;96(5):373\u2013381.10.1016\/S0049-3848(99)00125-510605952"},{"issue":"3","key":"b23","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12028-010-9435-1","article-title":"Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage","volume":"13","author":"Simard JM","year":"2010","unstructured":"Simard JM, Schreibman D, Aldrich EF, Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):439\u2013449.10.1007\/s12028-010-9435-120809188"},{"issue":"12","key":"b24","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1161\/STROKEAHA.116.014794","article-title":"Dissociation of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage","volume":"47","author":"Ayling OGS","year":"2016","unstructured":"Ayling OGS, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL. Dissociation of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(12):2945\u20132951.2782732410.1161\/STROKEAHA.116.014794"},{"issue":"4","key":"b25","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","article-title":"Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects","volume":"42","author":"Vergouwen MDI","year":"2011","unstructured":"Vergouwen MDI, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924\u2013929.2131106210.1161\/STROKEAHA.110.597914"},{"issue":"5","key":"b26","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1227\/NEU.0b013e318285c3db","article-title":"The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"72","author":"Brown RJ","year":"2013","unstructured":"Brown RJ, Kumar A, Dhar R, Sampson TR, Diringer MN. The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72(5):702\u2013708.10.1227\/NEU.0b013e318285c3db23313984"},{"issue":"4","key":"b27","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","article-title":"Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage","volume":"42","author":"Crowley RW","year":"2011","unstructured":"Crowley RW, Medel R, Dumont AS, Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke. 2011;42(4):919\u2013923.10.1161\/STROKEAHA.110.59700521350201"},{"key":"b28","series-title":"Acta Neurochir Suppl","first-page":"161","article-title":"Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage","volume":"120","author":"Dhar R","year":"2015","unstructured":"Dhar R, Diringer MN. Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:161\u2013165.25366617"},{"issue":"3","key":"b29","series-title":"J Vasc Res","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000084656","article-title":"Heparin regulates transcription of endothelin-1 gene in endothelial cells","volume":"42","author":"Kuwahara-Watanabe K","year":"2005","unstructured":"Kuwahara-Watanabe K, Hidai C, Ikeda H, Heparin regulates transcription of endothelin-1 gene in endothelial cells. J Vasc Res. 2005;42(3):183\u2013189.10.1159\/00008465615785094"},{"issue":"5 Pt 2","key":"b30","series-title":"Am J Physiol","first-page":"R1035","article-title":"Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats","volume":"263","author":"Yokokawa K","year":"1992","unstructured":"Yokokawa K, Mandal AK, Kohno M, Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol. 1992;263(5 Pt 2):R1035\u2013R1041.1443220"},{"issue":"8","key":"b1","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1161\/STROKEAHA.110.581975","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi T","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519\u2013e536.10.1161\/STROKEAHA.110.58197520595669"},{"issue":"10069","key":"b2","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"Macdonald RL","year":"2017","unstructured":"Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655\u2013666.10.1016\/S0140-6736(16)30668-727637674"},{"issue":"12","key":"b3","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","article-title":"The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage","volume":"85","author":"Budohoski KP","year":"2014","unstructured":"Budohoski KP, Guilfoyle M, Helmy A, The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014;85(12):1343\u20131353.10.1136\/jnnp-2014-30771124847164"},{"issue":"12","key":"b4","series-title":"Curr Atheroscler Rep","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology","volume":"19","author":"Geraghty JR","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50.2906330010.1007\/s11883-017-0690-x"},{"key":"b5","series-title":"Biomed Res Int","doi-asserted-by":"publisher","first-page":"384342","DOI":"10.1155\/2014\/384342","article-title":"Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage","volume":"2014","author":"Miller BA","year":"2014","unstructured":"Miller BA, Turan N, Chau M, Pradilla G. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int. 2014;2014:384342.2510512310.1155\/2014\/384342"},{"issue":"3","key":"b6","series-title":"Cochrane Database Syst Rev","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJE, Feigin VL, Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277.17636626"},{"issue":"7","key":"b7","series-title":"CNS Neurol Disord Drug Targets","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/187152711798072383","article-title":"Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage","volume":"10","author":"Liu GJ","year":"2011","unstructured":"Liu GJ, Luo J, Zhang LP, Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets. 2011;10(7):834\u2013844.10.2174\/18715271179807238321999736"},{"issue":"7","key":"b8","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald RL","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u2013625.2164065110.1016\/S1474-4422(11)70108-9"},{"key":"b9","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fneur.2018.00292","article-title":"Neuroinflammation as a target for intervention in subarachnoid hemorrhage","volume":"9","author":"De Oliveria Manoel AL","year":"2018","unstructured":"De Oliveria Manoel AL, Loch Macdonald R. Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol. 2018;9:292.10.3389\/fneur.2018.00292"},{"issue":"8","key":"b10","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/jcbfm.2009.59","article-title":"Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial","volume":"29","author":"Vergouwen MDI","year":"2009","unstructured":"Vergouwen MDI, Meijers JC, Geskus RB, Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab. 2009;29(8):1444\u20131453.1945860510.1038\/jcbfm.2009.59"},{"issue":"5","key":"b11","series-title":"Molecules","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/molecules22050724","article-title":"Heparin and heparin-derivatives in post-subarachnoid hemorrhage brain injury: a multimodal therapy for a multimodal disease","volume":"22","author":"Hayman EG","year":"2017","unstructured":"Hayman EG, Patel AP, James RF, Simard JM. Heparin and heparin-derivatives in post-subarachnoid hemorrhage brain injury: a multimodal therapy for a multimodal disease. Molecules. 2017;22(5):724.10.3390\/molecules22050724"},{"key":"b12","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fneur.2018.00097","article-title":"Heparin: the silver bullet of aneurysmal subarachnoid hemorrhage?","volume":"9","author":"Khattar NK","year":"2018","unstructured":"Khattar NK, James RF. Heparin: the silver bullet of aneurysmal subarachnoid hemorrhage?. Front Neurol. 2018;9:97.10.3389\/fneur.2018.0009729636721"},{"issue":"1","key":"b13","series-title":"CNS Drug Rev","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-3458.2002.tb00213.x","article-title":"Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review","volume":"8","author":"Stutzmann JM","year":"2002","unstructured":"Stutzmann JM, Mary V, Wahl F, Grosjean-Piot O, Uzan A, Pratt J. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review. CNS Drug Rev. 2002;8(1):1\u201330.10.1111\/j.1527-3458.2002.tb00213.x"},{"issue":"10","key":"b14","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen MDI","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20132395.2079837010.1161\/STROKEAHA.110.589275"},{"issue":"6","key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3171\/2013.8.JNS1337","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment","volume":"119","author":"Simard JM","year":"2013","unstructured":"Simard JM, Aldrich EF, Schreibman D, James RF, Polifka A, Beaty N. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment. J Neurosurg. 2013;119(6):1611\u20131619.2403270610.3171\/2013.8.JNS1337"},{"issue":"7","key":"b16","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/neurintsurg-2016-012925","article-title":"Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional \u2018H\u2019 therapy in vasospasm treatment","volume":"9","author":"Bruder M","year":"2017","unstructured":"Bruder M, Won SY, Kashefiolasl S, Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional \u2018H\u2019 therapy in vasospasm treatment. J Neurointerv Surg. 2017;9(7):659\u2013663.10.1136\/neurintsurg-2016-01292528153852"},{"key":"b17","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1016\/j.wneu.2018.06.118","article-title":"Low-dose versus therapeutic range intravenous unfractionated heparin prophylaxis in the treatment of patients with severe aneurysmal subarachnoid hemorrhage after aneurysm occlusion","volume":"117","author":"Kunz M","year":"2018","unstructured":"Kunz M, Siller S, Nell C, Low-dose versus therapeutic range intravenous unfractionated heparin prophylaxis in the treatment of patients with severe aneurysmal subarachnoid hemorrhage after aneurysm occlusion. World Neurosurg. 2018;117:e705\u2013e711.2995906610.1016\/j.wneu.2018.06.118"},{"issue":"5","key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3171\/2017.11.JNS17894","article-title":"Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes","volume":"130","author":"James RF","year":"2019","unstructured":"James RF, Khattar NK, Aljuboori ZS, Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes. J Neurosurg. 2019;130(5):1460\u20131467.10.3171\/2017.11.JNS17894"},{"issue":"3","key":"b19","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/neuros\/nyaa473","article-title":"Low-dose intravenous heparin infusion after aneurysmal subarachnoid hemorrhage is associated with decreased risk of delayed neurological deficit and cerebral infarction","volume":"88","author":"Kole MJ","year":"2021","unstructured":"Kole MJ, Wessell AP, Ugiliweneza B, Low-dose intravenous heparin infusion after aneurysmal subarachnoid hemorrhage is associated with decreased risk of delayed neurological deficit and cerebral infarction. Neurosurgery. 2021;88(3):523\u2013530.10.1093\/neuros\/nyaa47333269390"},{"issue":"6","key":"b20","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3171\/jns.2003.99.6.0953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"Siironen J","year":"2003","unstructured":"Siironen J, Juvela S, Varis J, No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg. 2003;99(6):953\u2013959.10.3171\/jns.2003.99.6.095314705720"},{"issue":"2","key":"b21","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clineuro.2004.01.006","article-title":"Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo","volume":"106","author":"Wurm G","year":"2004","unstructured":"Wurm G, Tomancok B, Nussbaumer K, Adelw\u00f6hrer C, Holl K. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg. 2004;106(2):97\u2013103.1500329810.1016\/j.clineuro.2004.01.006"},{"issue":"5","key":"b22","series-title":"Thromb Res","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0049-3848(99)00125-5","article-title":"The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells","volume":"96","author":"Young E","year":"1999","unstructured":"Young E, Venner T, Ribau J, Shaughnessy S, Hirsh J, Podor TJ. The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells. Thromb Res. 1999;96(5):373\u2013381.10.1016\/S0049-3848(99)00125-510605952"},{"issue":"3","key":"b23","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12028-010-9435-1","article-title":"Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage","volume":"13","author":"Simard JM","year":"2010","unstructured":"Simard JM, Schreibman D, Aldrich EF, Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):439\u2013449.10.1007\/s12028-010-9435-120809188"},{"issue":"12","key":"b24","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1161\/STROKEAHA.116.014794","article-title":"Dissociation of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage","volume":"47","author":"Ayling OGS","year":"2016","unstructured":"Ayling OGS, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL. Dissociation of early and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(12):2945\u20132951.2782732410.1161\/STROKEAHA.116.014794"},{"issue":"4","key":"b25","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","article-title":"Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects","volume":"42","author":"Vergouwen MDI","year":"2011","unstructured":"Vergouwen MDI, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924\u2013929.2131106210.1161\/STROKEAHA.110.597914"},{"issue":"5","key":"b26","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1227\/NEU.0b013e318285c3db","article-title":"The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"72","author":"Brown RJ","year":"2013","unstructured":"Brown RJ, Kumar A, Dhar R, Sampson TR, Diringer MN. The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72(5):702\u2013708.10.1227\/NEU.0b013e318285c3db23313984"},{"issue":"4","key":"b27","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","article-title":"Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage","volume":"42","author":"Crowley RW","year":"2011","unstructured":"Crowley RW, Medel R, Dumont AS, Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke. 2011;42(4):919\u2013923.10.1161\/STROKEAHA.110.59700521350201"},{"key":"b28","series-title":"Acta Neurochir Suppl","first-page":"161","article-title":"Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage","volume":"120","author":"Dhar R","year":"2015","unstructured":"Dhar R, Diringer MN. Relationship between angiographic vasospasm, cerebral blood flow, and cerebral infarction after subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:161\u2013165.25366617"},{"issue":"3","key":"b29","series-title":"J Vasc Res","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000084656","article-title":"Heparin regulates transcription of endothelin-1 gene in endothelial cells","volume":"42","author":"Kuwahara-Watanabe K","year":"2005","unstructured":"Kuwahara-Watanabe K, Hidai C, Ikeda H, Heparin regulates transcription of endothelin-1 gene in endothelial cells. J Vasc Res. 2005;42(3):183\u2013189.10.1159\/00008465615785094"},{"issue":"5 Pt 2","key":"b30","series-title":"Am J Physiol","first-page":"R1035","article-title":"Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats","volume":"263","author":"Yokokawa K","year":"1992","unstructured":"Yokokawa K, Mandal AK, Kohno M, Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol. 1992;263(5 Pt 2):R1035\u2013R1041.1443220"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/52\/3\/article-pE9.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/52\/3\/article-pE9.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/52\/3\/article-pE9.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:28:05Z","timestamp":1780734485000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/52\/3\/article-pE9.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":60,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2021.12.focus21419","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}